Case Study 10 Hysterectomy: Hospital Costs and Outcomes Study For NSW Health
Case Study 10 Hysterectomy: Hospital Costs and Outcomes Study For NSW Health
Other Industries
July 2010
Case study 10 - Hysterectomy
Hospital costs and outcomes study for NSW Health
Other Industries
July 2010
© Independent Pricing and Regulatory Tribunal of New South Wales 2010.
This work is copyright. The Copyright Act 1968 permits fair dealing for study, research,
news reporting, criticism and review. Selected passages, tables or diagrams may be
reproduced for such purposes provided acknowledgement of the source is included.
Contents
6 Configuration of care 38
Appendices 45
A List of full recommendations from main report 47
B Risk-adjusted indicators provided by NSW Health 57
Glossary 58
NSW Health asked the Independent Pricing and Regulatory Tribunal of NSW
(IPART) to conduct a costs and outcomes study that encompasses 3 components of
this larger project. The aim of the study was to provide information and analysis that
can be used by clinical experts to better understand the variation in clinical practice
in NSW hospitals, and the extent to which this variation can lead to differences in
hospital costs and clinical outcomes.
IPART’s hospital costs and outcomes study is part of a larger, multi-stage project NSW Health is
coordinating with the assistance of other organisations. The terms of reference for this project
set out 6 components:
1. Audit the quality of current coding and costing data.
2. Analyse differences in costs between 3 principal tertiary referral hospitals and 2 other
principal referral hospitals.
3. Describe the different configurations of care that underpin different cost profiles.
4. Analyse available data on differences in adjusted admission rates and clinical outcomes for
the 5 selected hospitals.
5. Determine whether variations in configurations of care lead to different clinical outcomes.
6. Identify the extent to which clinical variation exists, with the aim of achieving clinical best
practice and maximum efficiency.
The first component is being completed by Health Outcomes International (audit of costing)
and Pavilion Health (audit of coding). The results will assist the NSW Department of Health in
further developing episode funding, in line with the national agreement by COAG to move to a
more nationally consistent approach to activity-based funding. IPART has completed the
second, third and fourth components through our hospital costs and outcomes study. The
results of this study will be used by clinical experts in completing the fifth and sixth
components.
The NSW Health project is part of its response to the findings and recommendations made in
the Report of the Special Commission of Inquiry into Acute Care Services by Commissioner
Garling.a
a Flowing from the NSW Government’s response to the Garling Inquiry (Caring Together - The Health Action Plan for
NSW (2009)), ‘four pillars’ of clinical improvement have been established – Clinical Excellence Commission (CEC),
Agency for Clinical Innovation (ACI), Bureau of Health Information (BHI) and Clinical Education and Training Institute
(CETI). IPART’s analysis on costs, clinical practice and outcomes is to be considered by the NSW Department of Health
and clinical experts in these agencies to assess whether variations in configurations of care lead to different clinical
outcomes and to identify the extent to which clinical variation exists, with the aim of achieving clinical best practice
and maximum efficiency.
To compare costs, configurations of care and outcomes in the 5 study hospitals, we focused on
11 specific conditions or procedures in detail (as well as undertaking a broad, hospital-wide
analysis). These conditions/procedures are:
Hip joint replacement
Major chest procedures
Breast surgery
Cholecystectomy
Appendicectomy
Stroke
Cardiology – stents, pacemakers and defibrillators
Tracheostomy, or ventilation for greater than 95 hours
Cataract/lens procedures
Hysterectomy, and
Obstetric delivery.
In selecting these conditions/procedures, and the relevant indicators to compare for each, we
were advised by a clinical consultant (Dr Paul Tridgell) and a clinical reference group (Professor
Bruce Barraclough, Dr Anthony Burrell, Dr Patrick Cregan, Professor Phillip Harris, Professor
Clifford Hughes, Professor Brian McCaughan, Professor Peter McClusky, Dr Michael Nicholl,
Professor Ron Penny, Professor Carol Pollock and Dr Hunter Watt).
The case studies were selected to provide a range of surgical procedures and a range of
medical conditions that met one or more of the following criteria:
high volumes
high reported costs
high variability in reported costs
apparent differences in clinical practice, or
a range of models of care.
To conduct the case studies, we visited each of the hospitals and spoke with a range of staff,
including clinical, nursing, management, finance, coding and administrative staff. We also
collected a range of clinical and financial data from NSW Health, relevant area health services
and hospitals. By analysing the data and speaking with clinical experts, we established the
most suitable data available for comparing hospitals on a like-with-like basis.
For further information on our methodology and broad findings on costs, outcomes and
configurations of care, see our report NSW Health costs and outcomes study by IPART for selected
NSW hospitals. Our detailed findings on the other case study areas can be found in our reports
on each area.
Hysterectomy was selected as one of the clinical areas for detailed study because it
involves:
moderate volumes1
large differences in reported costs between hospitals despite a relatively uniform
patient type and similar length of stay
apparent differences in clinical practice (eg, surgical approach taken to perform
the hysterectomy).
The hysterectomy case study compared the costs and configurations of care related
to this surgical procedure. We used diagnostic related groups (DRGs)2 to define the
procedures and identify the data included in the scope of the case study. This case
study involved a single DRG (see Table 1.1).
Table 1.1 DRGs included in the scope of the hysterectomy case study
DRG Description
N04Z Hysterectomy for non malignancy
For this case study, we found that it was necessary to go beyond DRGs and we
identified subgroups of patients based on the principal type of surgery performed
(‘principal procedure’) to meaningfully compare costs, configurations of care and
outcomes. See Chapter 2 for further details.
Unless specified otherwise in this case study, the data we analysed related to the
12-month period from 1 July 2008 to 30 June 2009.
1.3 What were the key findings of the hysterectomy case study?
To compare the costs and configurations of care for hysterectomies at the study
hospitals, we collected, analysed and compared data on:
the type, number and mix of hysterectomy patients at each hospital
the average length of stay for these patients at each hospital
selected costs, or major clinical resources used to provide acute inpatient care for
these patients at each hospital
the configurations of care used to provide and manage hysterectomy patient care
at each hospital
indicators of outcome, safety and quality for hysterectomies for each hospital.
As noted above, we found it was necessary to go beyond the DRG level to identify
groups of reasonably similar patients. Therefore, we broke the data into 4 subgroups
based on the principal type of hysterectomy procedure performed. These subgroups,
which have different implications for costs and length of stay, were abdominal,
laparoscopic, vaginal and laparoscopically-assisted vaginal hysterectomy.
Abdominal surgery is the oldest method and has the longest length of stay. Vaginal
hysterectomy is not feasible for patients with a very large uterus.
We found that about 50% of patients in the study hospitals had abdominal surgery in
2008/09, and about 34% had vaginal surgery. BLH had the highest rate of abdominal
surgery (62% of cases), and RNSH had the lowest (44% of cases).
We found that the choice of procedure depends partly on the condition to be treated,
but also on the skills and preferences of the clinical staff.
3 Endometrial ablation is a process that destroys the lining of the uterus, and is used to treat
uterine bleeding (WebMD, http://women.webmd.com/endometrial-ablation-16200).
4 Uterine artery embolisation is used to treat uterine fibroids by blocking both uterine arteries
with particles injected via the femoral and uterine arteries (National Institute for Health and
Clinical Excellence, http://www.nice.org.uk/IPG94).
Our analysis shows that the average age of patients in all hospitals was 51 years old,
with only a small amount of variation between the hospitals. Almost all
hysterectomies were planned rather than emergency admissions.
We found that RNSH had a relatively low volume of hysterectomy cases relative to
its size, which probably reflects the volume of private cases undertaken in nearby
private facilities. GH had a high number of hysterectomies relative to its size.
Our analysis indicates that the measure often used in National Hospital Cost Data
Collection (NHCDC) and DRG benchmarking – the average ‘acute episode length of
stay’, is appropriate for the hysterectomy DRG because there were very few transfers
in or out of the study hospitals, and very few patients that recorded more than one
acute episode. We have reported only the acute episode length of stay (LOS1).
We found that RNSH has the highest 23 hour surgery rate and the highest proportion
of 1 or 2 day stays. GH has a shorter average length of stay, but this is because it has
a significantly smaller share of stays of more than 4 days. The comparatively long
average length of stay at RPAH and JHH is largely due to a small number of cases at
these hospitals with a length of stay exceeding 7 days. We also found that the
average length of stay is higher for abdominal hysterectomies than for vaginal
hysterectomies.
Finally, we found that there is a great deal of variation between treating physicians in
length of stay of their patients and the proportion of patients staying for only 1 or 2
days.
To compare the costs related to the case study areas at the study hospitals, we
examined the management and use of a selection of clinical resources used directly
for patient care in that area. For hysterectomy, the main clinical resources we
examined were nursing staff in wards, imaging, pathology, blood use, and operating
theatre time. We had aimed to also estimate medical staff costs and pharmacy costs
for this case study, but were unable to obtain consistent comparisons within the
timeframe for this review.5
5 Medical staffing and pharmacy are discussed in our main report, NSW Health costs and outcomes
study by IPART for selected NSW hospitals, July 2010, Chapters 9 and 14.
We found that the number of nursing hours per patient day (ie, the nursing staff-to-
patient ratio) is the main driver of the differences in the average cost per episode for
this DRG as a whole, partly because the length of stay is fairly uniform across the
hospitals (except JHH). However, we found that the average length of stay drives
the cost difference between different surgical procedures within each hospital.
We found that a more senior nursing staff mix – Clinical Nurse Specialists (CNSs)
and Registered Nurses (RNs) – was associated with fewer nursing hours per patient
day and a lower nursing cost per patient day. In particular, we found that JHH had
the lowest cost per patient day and the highest proportion of CNSs and RNs in its
staff mix, while BLH had lowest proportion of CNSs and RNs in its staff mix and the
highest cost per patient day.
The hospitals use inpatient fractions (IFRACs) to allocate staff time to acute care and
other staff responsibilities. We found that nursing costs are highly sensitive to the
IFRACs the hospitals apply to them. When all nursing costs are attributed to
inpatient care (ie, IFRAC=1), the cost variation between the hospitals is significantly
smaller than when the hospital’s IFRACs are used. Setting IFRAC equal to
1 increased RNSH costs the most, and changed its ranking from the lowest cost
hospital to the highest cost hospital (excluding RPAH).6
We found that imaging costs for this DRG were low at all the hospitals – less than
$50 per episode. Blood use costs were also low and ranged from $24 per episode at
RNSH to $91 per episode at BLH. Blood use was much higher for abdominal
hysterectomies than for vaginal hysterectomies.
Pathology costs ranged between $221 and $276 at all the hospitals except GH, where
the cost was significantly lower, at $87 per episode. It appeared that the GH
pathology data excluded many item numbers for the higher cost tests, which
accounted for the difference. We believe that these tests were performed at another
lab and not captured in the hospital imaging data. All the study hospitals did a
significant proportion of these tests on the day of admission.
6 We excluded RPAH from this analysis because the gynaecology ward moved during the year,
making the costs unreliable.
The NHCDC reports estimates of average hospital costs based on data it collects
from hospitals around Australia.8 In this study, we had access to the study hospitals’
provisional de-identified patient-level data for 2008/09, as well as the overall
averages publicly reported by the NHCDC for different hospital groupings in
2007/08.9 The final NHCDC estimates for study hospitals for 2008/09 became
available towards the end of our study. We compared these to the provisional costs
and found that some of the costs had changed substantially. Give the limited time
available, we used the final costs only where these were substantially different from
the provisional costs.
We were able to compare study hospitals’ NHCDC estimates with our estimates of
nursing, imaging and pathology costs. For pathology we used the final NHCDC
costs. We found there is a much smaller variation in our nursing costs across the
study hospitals than is implied by the NHCDC costs. We also found a higher degree
of consistency in the hospitals’ use of imaging and pathology than is reflected in the
NHCDC. Finally, we found that the NHCDC operating theatre costs vary over a far
wider range than differences in operating theatre time would indicate.
Due to time constraints, we did not have detailed discussions about configurations of
care for hysterectomies during our hospital visits.
However, we make the observation that JHH, RNSH and RPAH have specialist
gynaecology oncology units. These hospitals may have a more complex casemix
because some patients admitted through these units may be coded into this DRG
(N04Z - hysterectomy for non-malignancy). For example, we found a number of
cases with diagnoses like ‘carcinoma in situ of cervix, unspecified’ who were
included in this DRG.
7 NSW Health, Program and Product Data Collection Standards Product costing standards v1.0,
Reporting requirements v1.0, 2008/09, p 83.
8 In NSW, these cost estimates are often compiled by area health services, rather than individual
hospitals.
9 Commonwealth Department of Health and Ageing, National Hospital Cost Data Collection, Round
12, 2007-2008, September 2009.
DRG N04Z is not a uniform grouping but the differences are small compared with other
clinical conditions
Benchmarking studies of the performance of individual hospitals and the public and
private hospital sectors often use DRGs as the basis for comparing length of stay and
cost. This assumes that patients whose condition or procedure has been coded with
the same DRG are relatively similar. Models of casemix or episode-based funding
are based on similar assumptions.
The hysterectomy DRG does not recognise the complexity introduced by the range of
different conditions that hysterectomies are used to treat, and the different surgical
procedures that can be used. Ideally, comparisons between the hospitals should take
into account both of these factors. However, we note that the variations in length of
stay and cost between the different surgical procedures and hospitals are small
compared with DRGs for other clinical conditions, for example those for hip joint
replacement or major chest procedures.10
A higher share of RNs and CNSs does not necessarily mean higher nursing costs. A
more senior staff mix can means that fewer nursing hours are required.
10 See Case study 2 Major chest procedures Hospital costs and outcomes study for NSW Health and Case
study 1 - Hip joint replacement - Hospital costs and outcomes study for NSW Health.
1 That any future studies of hysterectomy compare the costs and outcomes for
hysterectomies with the costs and outcomes of other procedures such as
endometrial ablation and uterine artery embolisation. 39
The rest of this report discusses the findings of the hysterectomy case study in more
detail:
Chapters 2 and 3 discuss the main types of hysterectomy procedures and the
number and mix of patients at the study hospitals.
Chapter 4 compares the length of stay at the study hospitals, and analyses the
length of stay by treating physician.
Chapter 5 describes how we analysed the costs of hysterectomies by identifying
the main clinical resources used to provide inpatient care, then estimating and
comparing the level of each resource used at the study hospitals. It also compares
our cost estimates with estimates based on the provisional or final data reported
to NSW Health as part of the NHCDC.
Chapter 6 makes some general observations about configurations of care. Due to
time constraints we did not have detailed discussions about configurations of care
for hysterectomies during our hospital visits.
Chapter 7 discusses the indicators of outcome, safety and quality for hysterectomy
we identified as clinically meaningful. It then compares the available data on
these indicators across the study hospitals.
The appendices contain the complete list of recommendations for our hospital
costs and outcomes study, more detailed information on the data sources for risk-
adjusted outcome indicators and the glossary.
To meaningfully compare data on the costs, configurations of care and outcomes for
a particular condition or procedure, the patients to which the data relate must be
reasonably similar – to allow ‘like-with-like’ comparisons. As Chapter 1 discussed,
the hysterectomy case study includes a single DRG to identify clinical and financial
data related to patients who had undergone hysterectomies at the study hospitals.
However, our analysis of the data and discussions with clinicians indicates that there
is a diverse mix of patients within this DRG and several types of hysterectomy
procedures are performed.
For this case study, we could not separate the data on hysterectomies into subgroups
by diagnosis because there were such a large number of diagnoses related to this
procedure. However we did separate the data into subgroups based on the type of
hysterectomy procedure performed, which enabled further analysis of the different
care requirements associated with different procedures. The sections below list the
main types of hysterectomy patients and the main hysterectomy procedures.
There are four main types of hysterectomy procedures, which have different
implications for costs and length of stay.11 These are:
Abdominal surgery, which involves an incision through the abdominal wall. This
is the oldest method, and involves the longest hospital length of stay of about
5 days.
Laparoscopic hysterectomy, which involves 3 to 4 small incisions through the
abdominal wall. This method reduces the length of stay to around 3 days, but is
capital intensive in terms of the equipment used for the procedure.
Vaginal hysterectomy, which is performed entirely through the vaginal canal.
This method has the shortest length of stay of 1 to 2 days.
11 Comparisons of length of stay are discussed in Chapter 4. Length of stay estimates were also
provided by some study hospitals during the hospital visits, namely RNSH.
The choice of procedure depends partly on the clinical condition to be treated. For
example, vaginal procedures tend to deal with prolapse of the uterus while
abdominal surgery may be required when complications are expected or surgical
exploration is required. Vaginal hysterectomy is not feasible for patients with a very
large uterus (for example due to large fibroids). Laparoscopic procedures are more
appropriate to control bleeding.
But the choice of procedure may also depend on the skills and preferences of the
clinical staff. For example, we were advised that at RNSH there tend to be more
laparoscopic procedures due to the skill mix of the staff who often only do
gynaecological work. Clinicians who do vaginal and abdominal procedures tend to
cover obstetrics and gynaecology, as well as having more cases relating to
malignancy and pelvic floor problems.
Future comparisons by NSW Health or hospitals could compare the costs and
configurations of care for these other procedures, but we have not done so in this
study. Table 2.2 shows the number of endometrial ablation and uterine artery
embolisation procedures carried out at the study hospitals in 2008/09, as well as the
number of hysterectomy cases for comparison. Endometrial ablation was a fairly
common procedure in our study hospitals, particularly at GH. Uterine artery
embolisation was less commonly used.
15 Australian Institute of Health and Welfare, AR-DRG Data Cubes, Separation, patient day and
average length of stay statistics by Australian Refined Diagnosis Related Group (AR-DRG)
Version 5.0/5.1, Australia, 1998-99 to 2007-08, (http://d01.aihw.gov.au/cognos/cgi-
bin/ppdscgi.exe?DC=Q&E=/AHS/drgv5_9899-0708_v2).
We identified the total number of hysterectomy cases at each hospital during the
study period and the proportion of these that were emergency admissions. We then
compared the age of patients at each hospital.
The sections below discuss our analysis of patient numbers and the age of patients in
more detail.
16 We have only included cases if the first episode of the admission has a DRG of N01Z to avoid
counting any patients twice.
JHH and RPAH had similar numbers of cases at 204 and 200, respectively while GH
had 101 cases. RNSH performed only 52 cases, as did BLH. This relatively low
volume of cases at RNSH probably reflects the volume of private cases undertaken in
nearby private facilities.
RPAH performed the most abdominal hysterectomies (106) while JHH performed
the most vaginal hysterectomies (72). GH and BLH performed very few laparoscopic
or laparoscopically-assisted vaginal hysterectomies.
Box 3.1 provides more detail on how we calculated the number of cases at each
hospital.
The approach prevented double counting. It excluded patients that may be admitted for a
different condition and later be reclassified to a hysterectomy DRG.
Note that our approach means that the number of cases we identified will be less than the
number of separations in 2008/09.
Almost all hysterectomies were planned admissions, and there were very few
transfers in or out of the study hospitals (see Table 3.2).
Emergency admissions were identified by linking emergency department attendance data with
admitted patient data where the time of arrival and departure in the emergency department
matched with the admission time.
Due to data quality issues with the transfer in and transfer out fields in the admitted patient
data, transfers were calculated using a linkage key developed by the Australian Institute of
Health and Welfare.
The average age of patients in all hospitals was 51 years old. Patients were on
average oldest at RPAH (54 years) and youngest at GH (47 years). The youngest
patient was 20 years old and the oldest was 90 years old (see Table 3.3). For the
study hospitals combined, only 9% of patients were more than 70 years old and 6%
were less than 35 years old.
For each of our clinical case studies we have calculated three different lengths of stay
measures. These are LOS1, which is the acute episode length of stay; LOS2, which is
the total length of stay in study hospital; and LOS3, which is LOS2 plus allowance for
time in other hospitals - one transfer in and one transfer out.
However in the case of hysterectomies, the majority of patients have planned rather
than emergency surgery and there are very few transfers in and out of the study
hospitals. Almost all patients are discharged after the acute episode. This means
that there is no observable difference in the acute episode length of stay (LOS1), the
hospital length of stay (LOS2) and the total number of days in hospital (LOS3). The
measure often used in NHCDC and DRG benchmarking – the average ‘acute episode
length of stay’, is therefore appropriate for the hysterectomy DRG.
We found that RNSH has the highest 23 hour surgery rate and the highest proportion
of 1 or 2 day stays. GH has a shorter average length of stay, but this is because it has
a significantly smaller share of stays of more than 4 days. The comparatively long
average length of stay at RPAH and JHH is largely due to a small number of cases at
these hospitals with a length of stay exceeding 7 days. We also found that the
average length of stay is higher for abdominal hysterectomies than for vaginal
hysterectomies.
We found that there is a great deal of variation between treating physicians in length
of stay of their patients and the proportion of patients staying for only 1 or 2 days.
Table 4.1 compares the average length of stay for hysterectomy patients across the
study hospitals, using the acute episode measure (LOS1).
Table 4.1 Acute episode length of stay for all hysterectomy patients
RPAH and JHH have the longest length of stay, as shown in Table 4.1. However, a
significant part of this is due to a few patients with a long length of stay, for example
14 of the 27 patients with a length of stay or more than 7 days are at RPAH and 8 are
at JHH. Excluding these patients significantly reduces the difference in the length of
stay between the study hospitals.
There are significant differences in the average length of stay for different conditions.
For example, the average length of stay ranged between 6 days for ‘benign neoplasm
of ovary’ to 1 day for ‘abnormal findings in specimens from female genital organs,
abnormal cytological findings’. This suggests that there is probably complexity that
is not adequately captured in the DRG system.
100% 7 days or
more
90% 9
7 6 days
80% 6
29
25 25 5 days
70% 10 12
60% 49 4 days
60
50%
36 13 3 days
40%
30% 24 59 2 days
53
20% 12
23 1 day
10% 33
22 5
0%
RPAH GH RNSH BH JHH
RNSH does 10% of cases on a 23 hour basis, and over 33% of cases have a length of
stay of less than 2 days, as shown in Figure 4.1. The other hospitals have much lower
23 hour surgery rates.
Table 4.2 compares the average length of stay for hysterectomy patients by surgical
procedure.
Table 4.2 Acute episode length of stay for abdominal and vaginal hysterectomies
The average length of stay varies depending on the surgical procedure adopted. The
average length of stay at the study hospitals varied from 4.1 days to 5.0 days for
abdominal hysterectomies and from 2.7 days to 4.5 days for vaginal hysterectomies
(excluding case outliers with a length of stay of 12 days or more). This is a further
complication in the casemix that the DRG system does not pick up.
Further analysis showed that the longer length of stay for vaginal hysterectomies at
RPAH is mainly due to the small number of patients that are admitted for only 1 or 2
days for this procedure (see Figure 4.2).
100%
2 1
7 days or
90% 7
6 0 more
80% 2 11 6 days
70% 11 7
5 days
60% 19
50% 29 4 days
19 6
40%
3 days
30% 4
20% 16 2 days
14 18
10% 3
1 day
4
0%
RPAH GH RNSH BH JHH
Figure 4.3 Proportion of patients with 1or 2 day stays per treating doctor
23HrRate
100%
90%
% length of stay <=23 hrs
80%
70%
60%
50%
40%
30%
20%
10%
0%
0 5 10 15 20 25 30 35 40 45 50
<=2Day
100%
90%
% length of stay <= 2 days
80%
70%
60%
50%
40%
30%
20%
10%
0%
0 5 10 15 20 25 30 35 40 45 50
There is also significant variation between treating physicians in the average length
of stay, as show in Figure 4.4. In this figure each physician is again identified by the
number of hysterectomies performed in 2008/09. The horizontal axis shows the
number of hysterectomies per physician, and the vertical axis shows the average
length of stay. Each physician is represented by a blue diamond.
Figure 4.4 Average length of stay by number of hysterectomies per treating doctor
8
Average length of stay (days)
1
0 5 10 15 20 25 30 35 40 45 50
To compare the costs of caring for hysterectomy patients at the study hospitals, we
examined the major clinical resources used to provide inpatient care during their
‘acute episode’ (ie, using LOS1). The clinical resources we examined were:
nursing staff in wards
imaging
pathology
blood use
operating theatres.
The sections below discuss our analysis of the estimated costs for each of these
resources across the study hospitals. For some resources, they also compare our
estimated costs with estimates based on provisional or final data reported to NSW
Health by area health services as part of the NHCDC.17
Note that given the scope of our task for this study, we were not able to undertake a
full bottom-up costing of all the above resource categories. Instead, we used a range
of approaches, based on the most reliable and consistent data we could obtain in the
time available. The methodologies we used are outlined in the sections below, and
discussed in more detail in our report, NSW Health costs and outcomes study by IPART
for selected NSW hospitals. Also note that while senior and junior medical staffing is a
major cost for hysterectomies, we were not able to compare the use and management
of these clinical resources due to the lack of consistent data.
17 Due to time constraints we used final NHCDC data only where these were substantially
different from the provisional data. For this case study we used final NHCDC data only for
pathology costs.
5.1.1 Methodology
To analyse this cost and allow comparisons with the NHCDC, we focused on:
the cost of nursing staff in wards (ie, excluding those of nursing staff in operating
theatres or senior nursing categories that provide area-wide or hospital-wide
functions)
nursing costs for the acute episode only (ie, LOS1).
Our methodology for estimating nursing costs and its limitations are briefly
described in Box 5.1 and in more detail in Chapter 8 of the main report, NSW Health
costs and outcomes study by IPART for selected NSW hospitals.
We excluded RPAH from our analysis because the gynaecology ward at this hospital
moved during the year, making the costs unreliable.
IPART used a model for each hospital to allocate ward nursing costs to each DRG grouping and
compare nursing costs.
We calculated ‘nursing hours per patient day’, ‘nursing cost per patient hour’ and ‘nursing cost
per acute episode’ for 2008/09 by:
Mapping the wards in each hospital to cost centres – so we could use these to extract
relevant payroll information for each ward.
Extracting information from the payroll on nursing classification, nursing pay and nursing
hours worked for each ward.
Applying inpatient fractions to our total ward nursing cost – so we only included nursing
costs for acute patient care. Note that some hospitals have a fraction of ‘1’ where other
hospitals may have fractions like ‘0.95’ for similar wards.
Allocating ward nursing costs to all patients on the ward, based on their time on the ward
and the nursing service weights for their DRG.
Allocating a cost of nursing care to each patient - for each step of the patient’s stay in acute
care. Note that from patient level episode information we attributed a cost to each ward
transfer during their ‘acute’ episode.
We then applied our estimate of nursing cost per hour to the average length of the acute
episode to obtain an estimate of the ‘nursing cost per episode’. We also calculated costs with
IFRAC = 1 for comparison.
Qualifications
For our calculations, we included only direct costs of ordinary hours (excluding leave),
penalty rates and overtime, obtained from payroll data.
The number of ‘nursing hours per patient day’ depends on the occupancy rates of the
wards. A higher occupancy rate reduces the hours per patient day but such a change can
cause other issues, like outliers or access block.
The ‘nursing hours per patient day’ is the share of a patient’s use of the nursing staff based
on the nursing service weights. These service weights are not perfect and the mix of other
patients on the ward may impact on the nursing hours attributed to a patient and hence
their cost. The service weights do not take into account the generally higher cost of
patients at the start of their hospital stay.
Some wards have a mix of more acute care with rehabilitation. Fewer nursing hours and
lower costs are attributed to the ‘acute’ episode in such wards compared with wards in
hospitals that have a greater separation of roles (acute wards separate from rehabilitation).
Our nursing methodology excludes ‘wards’ like emergency departments where it is
particularly difficult to determine the inpatient fraction, but allocated a nursing cost for the
time spent in emergency.
Hospitals with a shorter reported length of stay for the ‘acute’ episode may be expected to
have a higher number of nursing hours per day and higher daily nursing costs.
The hospitals use inpatient fractions (IFRACs) to allocate staff time to acute care and
other staff responsibilities. We calculated two sets of inpatient nursing costs, the first
using the hospitals’ IFRACs and the second setting all IFRACs to 1.18 We did this
because we were concerned that IFRACs may not be consistently applied by the
hospitals.19
JHH has an IFRAC of 1, BLH and GH have IFRACs of 0.98 and 0.94 respectively,
while RNSH has an IFRAC of 0.79. These IFRACs may be valid, because ward
nursing staff (except at JHH) may spend time on non-inpatient activities (eg, staffing
outpatient clinics). However, the purpose of our analysis is to show how sensitive
the nursing cost estimates are to IFRACs. IFRACs also underlie the NHCDC
estimates of ward costs.
Table 5.1 contains comparisons of our estimates of the average ward nursing costs for
the study hospitals (excluding RPAH). The last column shows the direct nursing
costs from the provisional data for the NHCDC, which we compare with our
estimates of cost.
Our analysis indicates that the cost per episode is affected by three main factors:
IFRACs
nursing hours per patient day (ie, nursing staff-to-patient ratio)
nursing staff mix.
We found that these factors outweigh the impact of the length of stay on the average
cost per acute episode for the DRG as a whole, partly because the length of stay is
fairly uniform across the hospitals (except JHH). However, as discussed in section
5.1.4 below, we found that the length of stay accounts for most of the cost difference
between different surgical procedures within each hospital.
IFRACs affect both the nursing costs per acute episode and the nursing costs per
patient day (see Table 5.1 and Table 5.2). When all nursing costs are attributed to
inpatient care (ie, IFRACs=1), there is a smaller variation in nursing costs across the
study hospitals. Setting IFRACs to 1 has the biggest impact on RNSH, because the
IFRACs used at this hospital are comparatively low. When IFRACs are used, RNSH
has the lowest cost per episode ($807), but when IFRACs are set to 1, RNSH has the
highest cost per episode along with BLH (respectively $1,019 and $1,018).
18 Setting IFRACs to 1 means that we allocated 100% of the nursing time to inpatient care at the
hospitals for the purpose of comparison.
19 IFRACs may differ between the hospitals for valid reasons, because the ward nursing staff in
some hospitals may spend more time on outpatient activities than those in other hospitals. The
purpose of our analysis is to show how sensitive the nursing cost estimates are to IFRACs.
We found that the second factor, the number of nursing hours per patient day (which
reflects the nursing staff-to-patient ratio), outweighed the impact of length of stay on
the hospitals’ episode costs. For example, we estimated that the average cost of
nursing per acute episode is lower at JHH ($893) than at BLH ($1,002) when IFRACs
are used, even though JHH has a longer length of stay (4.5 days) than BLH (3.9 days).
The reason for this is that JHH has only 5.2 nursing hours per patient day compared
with 7.5 at BLH, which translates into a significantly lower cost per patient day at
JHH ($201) compared with BLH ($256). (See Table 5.2.)
The third factor is the nursing staff mix, which affects the average cost per nursing
hour as well as the number of hours per patient day (and hence the average cost per
patient day). A more senior staff means a higher cost per nursing hour, but fewer
hours per patient day. The net effect of this on the cost per patient day depends on
the extent to which the higher hourly cost of a more senior staff is offset by a lower
number of nursing hours.
Our analysis indicates that JHH has a far higher percentage of Registered Nurses
(RNs) and Clinical Nurse Specialists (CNSs) than any of the other hospitals (91%
combined), and therefore a higher average costs per nursing hour of $39 (Table 5.3).
But it still has the lowest cost per patient day ($201) because it has such a low
number of nursing hours per patient day (5.2 hours). Note however that the low
number of hours per patient at JHH may also be a consequence of other factors such
a high bed occupancy rate or staff shortages.
Conversely, BLH has the lowest percentage of RNs and CNSs (65%), and the lowest
costs per nursing hour ($34). But the high number of nursing hours per patient day
at BLH results in a significantly higher cost per patient day ($256).
The direct nursing costs from the provisional data for the NHCDC (Table 5.1, last
column and Figure 5.1) vary over a far wider range than our nursing cost estimates –
from $320 at JHH to $1,579 at GH. The costs for JHH are particularly low compared
with our cost estimates, while the costs for GH are significantly higher.
Table 5.1 Ward nursing costs per acute episode, with and without IFRACs
days $ no. $ $
RPAH 4.6 na na na 410
GH 3.6 925 0.94 987 1,579
RNSH 3.7 807 0.79 1,019 1,066
BLH 3.9 1,002 0.98 1,018 1,266
JHH 4.5 893 1.00 895 320
Note: Episode nursing cost calculated using acute episode LOS measure (LOS1).
Source: IPART analysis from HIE inpatient statistics, 2008/09, payroll data and provisional cost data 2008/09, NHCDC.
Table 5.2 Nursing costs and hours per patient day, with and without IFRACs
Hospital Nursing costs per patient day Nursing hours per patient day
With IFRAC IFRAC=1 With IFRAC IFRAC=1
$ $ hours hours
RPAH na na na na
GH 254 271 7.0 7.5
RNSH 217 273 6.2 7.9
BLH 256 260 7.5 7.7
JHH 201 201 5.2 5.2
Source: HIE inpatient statistics, 2008/09, payroll data and IPART analysis.
Figure 5.1 Comparison of direct ward nursing costs per acute episode ($)
1,800
1,600
1,400
$ per episode
1,200
1,000
800
600
400
200
-
RPAH GH RNSH BLH JHH
Source: IPART analysis from HIE inpatient statistics, 2008/09, payroll data and provisional cost data 2008/09, NHCDC.
20 Most of these long-stay cases are at JHH and RPAH, which have specialised gynaecology
oncology units and have a higher proportion of complex cases in their casemix.
Table 5.4 Ward nursing costs for abdominal and vaginal hysterectomies (excluding
long staya), with and without IFRACs
days $ $ $
Table 5.5 Nursing costs and hours, with and without IFRACs
Hospital Nursing costs per patient day Nursing hours per patient day
With IFRAC IFRAC=1 With IFRAC IFRAC=1
$ $ hours hours
Abdominal hysterectomies excluding long staya
RPAH na na na na
GH 258 275 7.1 7.6
RNSH 218 277 6.2 7.9
BLH 257 261 7.5 7.6
JHH 171 171 4.4 4.4
Vaginal hysterectomies excluding long staya
RPAH na na na na
GH 255 269 7.1 7.5
RNSH 202 252 5.9 7.4
BLH 254 258 7.5 7.7
JHH 179 179 4.7 4.7
a Cases with a length of stay of 12 days or more excluded.
Source: HIE inpatient statistics, 2008/09, payroll data and IPART analysis.
At all the hospitals, the episode cost for abdominal hysterectomy is higher than for
vaginal hysterectomy (Table 5.4). The main reason for this difference is the longer
length of stay for abdominal hysterectomies. Abdominal hysterectomies also require
slightly more nursing hours per patient day at all the hospitals except BLH and JHH
(Table 5.5).
The NHCDC costs similarly show higher costs for abdominal hysterectomies than
vaginal hysterectomies, although the range is far wider than our analysis indicates.
Table 5.6 sets out our calculations for the average cost of all imaging tests for
hysterectomy patients, during their acute episode and on the day of their admission.
It also sets out the average costs for selected high-cost tests (CT/MRIs, ultrasound
and fluoroscopy), as well as the direct and indirect imaging costs from the
provisional data for the NHCDC. Our methodology for calculating these costs is
explained in Box 5.2.
We found that the average cost of tests for hysterectomy patients is relatively low,
and varies from $47 at RPAH to $20 at RNSH. At RNSH most of the testing is done
on the day of admission, but this is not the case for the other hospitals. We also
found a higher degree of consistency in the hospitals’ use of imaging than is reflected
in the NHCDC (Table 5.6).
Table 5.6 Average value attributed to imaging during acute stay and on day of
admission ($)
$ $ $ $ $
Acute episode
RPAH 47 21 2 3 193
GH 29 19 7 - 37
RNSH 20 9 2 - 13
BLH 35 31 - - 241
JHH 44 20 4 1 91
Day of admission
RPAH 6 5 0 0 na
GH 0 0 0 0 na
RNSH 16 9 2 0 na
BLH 1 0 0 0 na
JHH 2 0 0 1 na
Source: IPART analysis using data from hospital imaging services and provisional cost data 2008/09, NHCDC.
We did not use a bottom-up costing approach to calculate imaging costs. Instead, we used
detailed information from imaging services on the number and type of tests performed, the
time and date. We use data for ‘acute’ episodes in 2008/09. As a proxy for cost, we attribute a
value based on the Medicare Benefits Schedule (MBS). Each test is valued at 100% of the MBS
fee.
More information is included in the main report, NSW Health costs and outcomes study by IPART
for selected NSW hospitals, Chapter 11 on imaging.
Table 5.7 shows the average pathology costs for hysterectomy patients. Our
methodology is explained in Box 5.3.
We found that pathology costs are in the region of $250 per patient at all hospitals,
except GH. We also found that all the hospitals do a significant proportion of
pathology test on the day of admission. Pathology test for hysterectomy involve a
combination of low cost tests and a higher charge for examination of the removed
tissue.
Our analysis showed that the cost for pathology tests at GH was far lower than at the
other hospitals ($87). However, it appears that GH imaging data excludes many item
numbers for the higher costs tests. These tests are believed to be performed
elsewhere and not captured in the GH imaging data system. An examples is the item
number 72824:
Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including
specimen dissection, all tissue processing, staining, light microscopy and professional
opinion or opinions - 2 to 4 separately identified specimens.
The MBS value of this item is currently $142. Adding this item to GHs costs would
increase its cost to $229, which is similar the other hospitals’ costs.
We found a far higher degree of consistency in the hospitals’ use of pathology for
diagnostic purposes than reflected in the NHCDC.
We did not use a bottom up costing for pathology. Instead, we attributed a value for pathology
tests based on internal billing data between the hospitals and the pathology services. We also
used information on the time and date of tests.
Charging arrangements at each hospital are similar, but are not identical. All pathology
services base their charges on the Medicare Benefit Schedule.
More information is included in the main report, NSW Health costs and outcomes study by IPART
for selected NSW hospitals, Chapter 12 on pathology costs.
We obtained detailed blood use data for each hospital, and calculated blood costs by
using an attributed cost of $250 per unit of blood. We found that the average cost of
blood for hysterectomy patients was relatively low. Blood use was much higher for
abdominal hysterectomies than for vaginal hysterectomies, and was particularly high
for abdominal surgery at BLH (Table 5.8).
We compared operating theatre time for the various hysterectomy procedures at the
study hospitals. We also compared operating theatre times with NHCDC operating
theatre costs.
We found that in general, operating theatre time (time from when surgery
commenced to when surgery was completed) was shorter for vaginal hysterectomies
than for abdominal hysterectomies, except at RNSH (Table 5.9). The average time of
surgery involving a laparoscope was longer than for either abdominal or vaginal
surgery. A laparoscopic hysterectomy took on average 62 minutes longer than an
open abdominal hysterectomy, while a laparoscopically-assisted vaginal
hysterectomy took 36 minutes longer than an open abdominal hysterectomy.
We cannot directly compare our analysis of operating theatre times with the NHCDC
operating theatre costs, because the NHCDC costs include items that are not related
to time spent in surgery (such as goods and services and some anaesthetic
department costs)21. However, we note that there is a significantly wider variation in
the NHCDC costs22 than in operating theatre times.23 For example, Figure 5.2 shows
that the NHCDC cost for:
abdominal surgery at JHH is 2.7 times the cost at RNSH (which has the lowest
cost), while the surgery time at JHH is about 1.5 times the surgery time at RNSH
vaginal surgery at JHH is 1.9 times the cost at RNSH, even though average theatre
time at JHH is about 8 minutes shorter than at RNSH.
21 NSW Health, Program and Product Data Collection Standards. Product costing standards v1.0,
Reporting requirements v1.0, 2008/09, p 83.
22 We used the provisional NHCDC costs for abdominal and vaginal surgery, scaled down in
proportion to the change in total operating theatre costs between the provisional and final
NHCDC data.
23 Operating theatre times may not be fully comparable between hospitals because they use
different systems to capture their theatre times.
Table 5.9 Operating theatre times and NHCDC costs for abdominal and vaginal
hysterectomies
Minutes $
Abdominal hysterectomy
RPAH 127.3 3,775
GH 93.7 3,377
RNSH 71.4 1,599
BLH 145.4 2,909
JHH 110.3 4,320
Vaginal hysterectomy
RPAH 107.0 3,345
GH 86.0 3,158
RNSH 84.6 1,894
BLH 111.8 2,909
JHH 77.0 3,519
a These are the provisional NHCDC costs for abdominal and vaginal surgery scaled down in proportion to the change
in total operating theatre costs between the provisional and final NHCDC data.
Note: Operating theatre times may not be fully comparable between hospitals because they use different systems to
capture their theatre times.
Source: IPART analysis using data from hospital operating theatres and NHCDC costs, 2008/09.
Figure 5.2 Ratio of time in surgery and NHCDC costs to RNSH time and costs for
abdominal and vaginal surgery (RNSH = 1)
3.0 3.0
2.5 2.5
2.0 2.0
1.5 1.5
1.0 1.0
0.5 0.5
RPAH GH RNSH BLH JHH RPAH GH RNSH BLH JHH
Source: IPART analysis using data from hospital operating theatres and provisional NHCDC costs, 2008/09.
Overall, we believe that the NHCDC costs for 2008/09 could be misleading. They
could be improved by using standard clinical feeds (ie, actual patient data from
clinical systems) in the costing process, similar to the process we have used for our
analysis. The standard clinical data used in costing could also be used to provide
useful data for clinicians and others to compare resource use and performance.
We also believe that the Department needs to establish more ‘rules’ to ensure
consistent data for the NHCDC, and needs to audit the IFRACs and cost centres
regularly.
6 Configuration of care
The term ‘configurations of care’ refers to the way that hospitals choose to manage
and provide patient care, including their clinical practices. The particular
configurations of care within a hospital can be influenced by a complex array of
factors, including national or state-wide guidelines or protocols, the culture, practices
and controls of the individual hospital, the culture and practices of each clinical unit
and its leadership and the preferences of each clinician. Differences in the way
hospitals manage and provide patient care can also lead to differences in the costs
and outcomes of that care.
Due to time constraints we did not have detailed discussions about configurations of
care for hysterectomies during our hospital visits, and we can therefore make only
three very general observations.
The first observation relates to the regional role of RPAH, RNSH and JHH which,
along with 4 other NSW public hospitals, have specialist gynaecology oncology
units.24 These centres for gynaecological oncology were established by NSW Health
to improve clinical outcomes by concentrating treatment at a few hospitals. These
hospitals may have a more complex casemix, because some patients admitted
through these units may be coded into this DRG N04Z “hysterectomy for non-
malignancy”. For example, we found a number of cases with diagnoses like
‘carcinoma in situ of cervix, unspecified’ who were included in this DRG.
Recommendation
1. That any future studies of hysterectomy compare the costs and outcomes for
hysterectomies with the costs and outcomes of other procedures such as endometrial
ablation and uterine artery embolisation.
25 Clinical Excellence Commission, Quality and Safety of Health Care in NSW, version 10 (confidential
draft of Tuesday 5 July 2009), pp 130-133.
The terms of reference for this study required us to analyse available data on
differences in clinical outcomes across the 5 study hospitals. However, while there
are a number of safety and quality indicators being collected locally, at the state level
and through clinical registries, there are few clinically agreed outcome indicators. As
such, we found that data on only a few indicators of clinical outcomes are collected
consistently across hospitals, or on a state-wide (or national) basis. Therefore, we
worked with clinical experts to establish a set of outcome, safety and quality
indicators that are clinically relevant, and for which we could feasibly obtain data in
the timeframe for our study.
The sections below set out the clinical indicators we selected for hysterectomy.
To identify the indicators we should focus on for this study, we worked with a
number of eminent clinicians on our Clinical Reference Group26 to develop a set of
outcome indicators. We also consulted clinicians in study hospitals and sought
further advice from clinicians with specific expertise in the fields of interest, as well
as other relevant organisations.
26 In the early stages of the review when indicators were being selected, our Clinical Reference
Group comprised Professor Bruce Barraclough, Professor Clifford Hughes, Dr Michael Nicholl,
Professor Ron Penny and Dr Hunter Watt. A number of other clinicians later joined the Clinical
Reference Group and many other clinicians in study hospitals were consulted as part of this
process.
In addition, hospitals treat patients with different mixes of illnesses, which can
influence the likelihood of adverse outcomes at the hospitals. To make meaningful
and fair comparisons of the performance of the study hospitals on some outcome
indicators, the analyses were risk-adjusted for factors outside the control of the
hospitals (ie, differences in patient characteristics – see Box 7.1).
Appendix B provides further details for the risk-adjusted indicator provided by NSW
Health, including the data sources used, the relevant time period for the data and the
adjustment factors applied.
Box 7.1 How data on indicators was risk-adjusted for differences in patient
characteristics
To meaningfully compare the performance of the study hospitals on some outcome indicators,
the hospitals’ data on these indicators needed to be risk-adjusted to account for differences in
patient characteristics that can influence the likelihood of adverse outcomes. In particular, NSW
Health adjusted data on mortality rates for the following patient characteristics:
age
sex
comorbidity, and
socio-economic status.a
To adjust for comorbidity, NSW Health used the Charlson index. This index simplifies the wide
range of comorbidities that may affect patients. It groups clinical conditions together (using
ICD 10), and assigns numerical weights (eg, 1, 2, 3) to them, based on the risk of dying
associated with the condition.b Adding together the numerical weights for a patient’s
comorbidities determines the patient’s combined Charlson index score, and therefore the
severity of their comorbidities
To make these adjustments, NSW Health used logistic regression in SAS 9.2. Where there were
sufficient numbers, it took repeated measures for the same person into account using multi-
level modelling. Where the number of events was too low to allow the above adjustment to be
carried out in full, the degree of adjustment was reduced and this was noted for each indicator.
a The ABS Index of Relative Socio-Economic Disadvantage (IRSD) was used to estimate socio-economic status. The
IRSD was assigned at Local Government Area level and grouped into quintiles from least disadvantaged to most
disadvantaged for analysis.
b Australian Institute of Health and Welfare, D Ben-Tovim, R Woodman, J Harrison, S Pointer, P Hakendorf & G Henley,
Measuring and reporting mortality in hospital patients, March 2009, p 18, (http://www.aihw.gov.au/publications/hse/hse-
69-10729/hse-69-10729.pdf).
Table 7.1 lists the 2 indicators we selected for hysterectomy. These indicators relate
to the outcomes of care.
NSW Health calculated and provided 30-day mortality rates to compare hospital
outcomes for hysterectomy patients. Box 7.2 explains the method used by NSW
Health to calculate mortality and survival rates.
However, the analysis found that there were fewer than 5 deaths following
hysterectomies in the 5 hospitals over the 3-year period 2005/06 to 2007/08. The
number of deaths was too small to allow comparisons between the hospitals.
The NSW Department of Health’s Centre for Epidemiology and Research calculated risk-
adjusted odds ratios for mortality for patients treated in each study hospital in the
hysterectomy case study area, using the methodology outlined below. We note that the NSW
Department of Health does not usually undertake this type of analysis.
Data sources
The analysis for mortality and survival, apart from in-hospital mortality, was carried out using
linked records of the NSW Admitted Patient Data Collection (APDC) and NSW Registry of Births,
Deaths and Marriages death registration data. The analysis for in-hospital mortality was carried
out using linked records of the APDC. In-hospital deaths and deaths from all causes were
included for all relevant indicators.
Case-based analysis
As one person may have more than one admission for a specified condition, the analyses were
‘case-based’, where a case represents a hospital admission for a specified condition. This
means that, for example, if a person died after 2 hospital admissions for a specified condition
and the death occurred within the period specified by the indicator, then the case and
therefore the death would be counted twice.
Indicators were adjusted for patient age, sex, comorbidity and socio-economic status as
described in Box 7.1.
Hospitals that were not significantly different in the adjustment model (at p<0.05) were
grouped.
Appendices
Our recommendations in this area are mainly aimed at making users of hospital data
aware of some of the limitations of using DRG groupings for hospital comparisons in
certain clinical areas.
1. That users of hospital cost and outcome data note that DRGs may contain a range of
patient types with varying clinical resource requirements, costs of care and expected
clinical outcomes. Therefore DRGs may not always provide the optimal basis for
comparing costs and outcomes among hospitals.
2. In light of Recommendation 1, that the NSW Department of Health, and other health
research bodies at both the state and national level, consider whether DRGs are a
suitable basis for determining funding and comparing performance among hospitals
(for various different types of hospital activity). Where they are not suitable, continue
research to develop better approaches for these areas.
Coding
Clinical costing
Our recommendations are aimed at improving the quality and consistency of clinical
costing data, and helping to ensure that quality costing data and clinical inputs to the
costing process (such as data from prosthesis, pathology and imaging systems) can
be used to inform hospital management about resource use, and clinicians about
clinical practice.
12. That the NSW Department of Health works with the area health services and hospitals
to apply a consistent set of rules for clinical costing covering cost centres and IFRACs
so that data are consistent and comparable between the hospitals.
13. That NSW Health regularly audits the accuracy of cost centres and IFRACs used for
clinical costing.
14. That NSW Health uses standard clinical data feeds (actual patient data) for clinical
costing where this is feasible and useful.
15. That the data used for clinical costing purposes be available to hospitals and clinicians
so they can undertake comparative analysis on clinical practices and performance.
Given our finding that there was a lack of consistency in the treatment of medical
staff costs and the difficulty this created in estimating medical staff costs for our
case study areas, we recommend:
16. That further work be undertaken to strengthen the quality and consistency of
available information on medical staff costs.
Prosthesis costs
19. That NSW Health facilitates sharing of information on purchase prices for prostheses
to assist price negotiations with suppliers.
20. That NSW Health optimises prosthesis cost savings through tenders, supplier price
agreements and controlled approaches to prosthesis purchasing, noting that clinical
consultation and cooperation is essential as is retaining some flexibility to allow for
special orders when clinically indicated.
Pharmacy costs
Our case studies identified a number of differences in the way care is provided
among study hospitals in specific clinical areas. We recommend that clinical experts
consider these clinical differences or clinical issues as part of Stages 5 and 6 of the
wider health study. This recommendation should be dealt with in conjunction with
Recommendation 36, relating to variation in indicators of safety, quality and
outcomes.
31. That NSW Health arranges for appropriate clinical expert groups to consider the
following clinical issues identified in our case studies; and that where appropriate,
NSW Health and the expert groups take steps to address clinical differences.
– Hip joint replacement:
o Note that separation of planned and emergency cases may reduce lengths of
stay for planned (arthritis) cases.
o Address the variation in the selection of hip prosthesis components (including
press fit, cementless hip stems versus cemented hip stems and ceramic femoral
heads versus metal femoral heads) among study hospitals.
– Major chest procedure:
o Note the different clinical pathways and high day of surgery admission rates for
thoracic surgery patients at RPAH compared with other study hospitals.
o Consider whether aspects of the model of care at RPAH are suitable to be used
in other hospitals.
– Breast surgery:
o Note the early discharge models at RNSH for breast surgery patients having
mastectomies and
o Consider whether such models should be followed more widely in NSW
hospitals and the types of patient cases they should be used for (eg, simpler,
unilateral cases or younger patients).
– Cholecystectomy:
o Note the variation in the proportion of patients with cholelithiasis or
cholecystitis who are operated on acutely as emergency admissions.
o Consider whether this variation has significant quality of care implications.
o Consider the relative costs and benefits of an emergency surgical services team
model for ensuring early diagnosis and treatment of conditions like
cholecystectomy and whether it should be more widely applied.
o Note that costing of cholecystectomy should take into account the costs of
prior related emergency department attendances. A similar approach should
be adopted for other clinical conditions that are likely to involve multiple prior
emergency department attendances.
o Consider the relative costs and benefits of cholecystectomies with and without
the use of fluoroscopy.
– Appendicectomy
o Note the variation in the use of imaging tests for diagnosing appendicitis.
o Consider establishing standard protocols for diagnosing appendicitis,
indicating when it is appropriate to use CT scans, MRIs and ultrasounds.
o As part of establishing standard protocols for diagnosing appendicitis, consider
whether CT scans, MRIs and ultrasounds should only be used for certain patient
groups (eg, older patients who are more likely to be suffering from other
conditions with symptoms similar to appendicitis).
o Consider the relative costs and benefits of laparoscopic versus open surgery for
appendicitis.
– Stroke
o Consider ways to reduce the proportion of stroke patients coded with a
principal diagnosis of 'stroke, not specified as haemorrhage or infarction'
(ICD10 code I64).
o Consider developing consistent guidelines for the administration of tPA.
o Consider including tPA administration as a procedure in coding standards.
o Consider ways to improve transfers of suspected stroke patients to stroke units
with minimum delay, including consultation with the Ambulance Service and
Emergency Departments.
o Investigate whether it is useful and possible to combine Ambulance Service
data on response time with hospital patient data to monitor time from call to
ambulance to arrival at an appropriate hospital.
o Consider the costs and benefits of providing more rehabilitation care in the
home.
o Pursue the collection of the data on outcome indicators from the National
Stroke Research Institute.
– Cardiology – Stents, Pacemakers and Defibrillators:
o Address the variation in the use of drug-eluting stents versus bare metal stents
among study hospitals.
o Address the variation in the types of pacemakers used among study hospitals.
o Investigate whether there are differences in treatment procedures, or waiting
times between presentation and procedure, for patients who present to
hospitals without a 24 hour cardiac catheter laboratory, compared to patients
who present to hospitals with a 24 hour cardiac catheter laboratory, and
whether any differences in procedure or waiting times have implications for
clinical outcomes.
While current Commonwealth and State initiatives will improve outcomes data, we
have made recommendations that will assist this process.
32. That NSW Health enhances understanding and use of mortality, survival, unplanned
readmission and wound infection indicators and their risk adjustment by:
– continuing to contribute to the development of ACSQHC’s safety and quality
standards for these indicators
– refining the methodology used for standardising or risk-adjusting these indicators
– continuing to consult with clinicians regarding the agreed presentation of
mortality, survival unplanned readmission and wound infection information
– reporting this information on a more routine and regular basis consistent with
ACSQHC data sets.
33. That NSW Health encourages hospitals to put in place systems to facilitate accurate
coding of comorbidities and ensures that coding practices are consistent across
hospitals.
34. That NSW Health works with ACSQHC to negotiate more streamlined arrangements
for access to data held by third parties (such as clinical registries) for clinical analysis,
and makes these data available to hospitals and clinicians.
35. That NSW Health explores the possibility of providing outcomes information to
clinicians in a more systematic way as an aid to clinical improvement and a key
indicator of performance.
We made recommendations to consider the costs and benefits of collecting data for
the following areas where indicators are not commonly used.
37. That NSW Health considers the costs and benefits of collecting data and monitoring
performance against the following indicators:
– warfarin management
– visual outcomes for patients undergoing lens procedures.
Table B.1 indicates the data sources and risk adjustment factors used for the risk-
adjusted indicator provided by NSW Health.
Glossary